The FDA is seeking feedback on a list of patient preference areas that it put together to help them take into account patients’ views as they make regulatory decisions about medical devices. Included on this list of patient preference areas is “Ear, Nose, and Throat: Treatments for moderate to severe hearing loss (implanted hearing devices vs. other treatment options).”
The FDA is seeking information or qualitative or quantitative assessments of whether patients prefer certain alternatives, outcomes or choices over others in terms of their health.
The FDA wants to understand how patients view the risks and benefits of a technology or treatment differently from how the risks and benefits are viewed by health-care professionals and caregivers and whether differences in patient perspectives are not well understood due to a variety of factors.
Check out their request for comments on the Federal Register.
Recent Posts
Use of Medications for Depression by Adults in the United States
Adult patients who seek audiological services may be taking prescription medication(s). This may include medications for depression. As such, a recent report by Elgaddal and…
Announcing Our Academy Board of Directors Elected Members 2025–2026
Thank you to everyone who voted, we are so pleased to announce the newly elected members-at-large and president-elect who will join your Academy Board of…
Academy, ADA, and ASHA Announce the Introduction of MAAIA in the Senate
The American Academy of Audiology, Academy of Doctors of Audiology (ADA), and American Speech-Language-Hearing Association (ASHA) are pleased to announce the introduction of the Medicare…